LENZILUMAB OUTCOMES ACCORDING TO RACE OF COVID-19 PARTICIPANTS IN THE LIVE-AIR PHASE 3 TRIAL

Vincent C. Marconi, Adrian Kilcoyne, Franklin Cerasoli, Christopher Polk, Meghan Lewis, Charles D. Burger, Edward Jordan, Cameron Durrant, Dale Chappell, Zelalem Temesgen
doi: https://doi.org/10.1101/2022.08.18.22278867

Data Availability

All data produced in the present work are contained in the manuscript

Back to top
Posted August 21, 2022.
Download PDF
Data/Code
Email
LENZILUMAB OUTCOMES ACCORDING TO RACE OF COVID-19 PARTICIPANTS IN THE LIVE-AIR PHASE 3 TRIAL
Vincent C. Marconi, Adrian Kilcoyne, Franklin Cerasoli, Christopher Polk, Meghan Lewis, Charles D. Burger, Edward Jordan, Cameron Durrant, Dale Chappell, Zelalem Temesgen
medRxiv 2022.08.18.22278867; doi: https://doi.org/10.1101/2022.08.18.22278867
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area